# Arbutus Biopharma Corp: Form 10-K/A for the period ended Mar 31, 2017

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: 10-K/A
- Filed: 2017-05-17
- Accepted by EDGAR: May 17, 2017, 16:56 ET
- Period: 2017-03-31
- Accession: 0001628280-17-005644
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000162828017005644/a2016arbutus10-ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000162828017005644/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000162828017005644/a2016arbutus10-ka.htm

Filed May 17, 2017.
Source: SEC EDGAR, the filing index for accession 0001628280-17-005644. Last ingested by Listed: Nov 12, 2026, 17:55 ET. No prices; not investment advice.
